Recombinant murine granulocyte colony-stimulating factor protects against acute disseminated Candida albicans infection in nonneutropenic mice

J Infect Dis. 1998 Jan;177(1):175-81. doi: 10.1086/513812.

Abstract

The effect of recombinant granulocyte colony-stimulating factor (rG-CSF) on acute disseminated Candida albicans infection in nonneutropenic mice was investigated. Mice treated with a single dose of rG-CSF showed a significantly reduced mortality (28% vs. 90%; P < .001). The outgrowth of C. albicans from the kidneys, spleens, and livers of rG-CSF-treated mice was significantly reduced (log cfu/g of kidney, 5.54 vs. 7.13; P < .001), as were circulating tumor necrosis factor-alpha and interleukin-1beta. After rG-CSF, the kidneys showed fewer infectious infiltrates, enhanced granulocyte influx, and almost complete absence of hyphal outgrowth. During peritoneal C. albicans infection, rG-CSF enhanced influx of granulocytes to the site of infection, and exudate granulocytes showed increased oxygen radical production. These results indicate that rG-CSF enhances host resistance to disseminated candidiasis in nonneutropenic mice through activation of granulocytes and their recruitment to the site of infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Candidiasis / drug therapy*
  • Disease Progression
  • Female
  • Granulocyte Colony-Stimulating Factor / administration & dosage
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Granulocytes / immunology
  • Interleukin-1 / metabolism
  • Kidney / microbiology
  • Liver / microbiology
  • Mice
  • Mice, Inbred CBA
  • Peritoneum / immunology
  • Peritoneum / microbiology
  • Reactive Oxygen Species / metabolism
  • Specific Pathogen-Free Organisms
  • Spleen / microbiology
  • Tumor Necrosis Factor-alpha / drug effects
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Interleukin-1
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha
  • Granulocyte Colony-Stimulating Factor